Males vs females: differences in the AB accumulation by Ordóñez-Gutiérrez, Lara et al.
Cortex 
Lara Ordóñez-Gutiérrez1,2 & Iván Fernández2, Marta Antón1,2 and Francisco Wandosell1,2 
1Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED) 
2 Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM), Universidad Autónoma de Madrid 
Males vs females:  
differences in the Aß accumulation  
Older females showed increased levels of Aß40 in peripheral plasma and cerebellum, but not in cortex 
Abstract 
Background: The accumulation of extracellular amyloid-beta (Aß) peptide and intracellular neurofibrillary tangles in the brain are two major neuropathological hallmarks of Alzheimer's 
disease (AD). For the analysis of Aß-peptide aggregation, different mouse models (single or double transgenic mice) have been used to follow the evolution of AD-amyloidosis, and to test 
potential treatments. So far, cerebellum tissue has not been deeply analyzed to check the amyloidosis in these transgenic models. Besides, sex influence hasn't been systematically studied 
in these models, even it has been described important gender differences in the evolution of AD in human population. We have checked whether the progression of amyloidosis in a 
double transgenic mouse, APP/PS1, is susceptible to aging and differentially affects males and females.  
Methods: Aß levels were measured by ELISA in plasma and tissue samples. Cortex and cerebellum tissue of transgenic males and females from 6 to 15 months of age were processed to be 
analyzed. In addition, fixed hemibrains brain were coronally sectioned and used to perform immunohistochemistry and immunofluorescence studies.  
Results: Peripheral levels of Aß presented different levels at 15months-old, being significantly higher in females. This divergence is observed in cerebellum analysis too. The accumulation 
of amyloid in the cerebellum was 10 fold higher in the females at 15 months. However, cortex results didn't show such differences between sexes. Immunohistochemistry and 
immunofluorescence analysis confirm ELISA results. Furthermore, the distribution of reactive glial cells showed important differences between cortex and cerebellum.  The levels of 
astrocytes in the molecular layer of the cerebellum were significantly reduced. 
Conclusions: The cerebellum tissue should be deeply analyzed to follow its implications in the evolution of the disease and the developed pathology. Moreover, gender differences could 
be crucial for a complete understanding of this disease. We suggest that human population could be studied in this way. In addition, sex specific treatment strategies could be developed, 
even more, differential response after any therapeutic approach could be observed too.  
Age Genotype n Sex 
6m Tg 4-6 ♂ 
6m Tg 4-6 ♀ 
9m Tg 4-6 ♂ 
9m Tg 4-6 ♀ 
12m Tg 4-6 ♂ 
12m Tg 4-6 ♀ 
15m Tg 4-6 ♂ 
15m Tg 4-6 ♀ 
Analyzed groups 
APP/PS1 transgenic 
mouse model 
Cerebellum 
ELISA 
Hemisphere 
Immunohistochemistry 
Immunofluorescence 
Greater  Aß plaques burden in older female’s cerebellum 
Reduced glia reaction in the cerebellum molecular layer  
6 m o n t h s 
1 5 m o n t h s 
6 E 1 0 
G F A P 
D A P I 
M L 
M L 
M L 
M L 
G L G L 
G L G L 
No sex differences in the Aß accumulation in the cortex 
Most of Aß plaques are surrounded by reactive glia cells  
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Conclusions 
 The peripheral levels of Aß in old females were greater than those observed in the males 
at the same age 
 Levels of Aß in the cerebellum were higher in 15-month females than in males at the 
same age 
 Not statistically significant differences were found in the Aß burden in the cortex 
between males and females 
 Cerebellum analyses showed an increase in the Aß burden with the age as it occurs in the 
cortex and hippocampus;  developed Aß plaques presented similar structure 
 Cerebellum molecular layer presented a very reduced levels of reactive glia cells 
 Biochemical  analysis (data not shown) confirm gender differences in some important 
markers; neuronal, survival and autophagic  pathways 
Plasma 
0
500
1000
1500
2000
2500
6 9 12 15
pg
/m
l 
months 
Aß1-40 levels in plasma 
Females
Males
* 
100
1000
10000
100000
6 9 12 15 months 
Aß1-40 in cerebellum (ng/mg) (log) 
Females
Males
100
1000
10000
100000
6 9 12 15 months 
Aß 1-40 in cortex (ng/mg) (log) 
Females
Males
* 
** 
